Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma

• Published in: BJUI compass Vol. 3; no. 1; pp. 37 - 44
• Main Authors: Alhalabi, Omar, Campbell, Matthew T., Xiao, Lianchun, Adriazola, Ana C., Wilson, Nathaniel R., Siefker‐Radtke, Arlene O., Corn, Paul G., Zurita, Amado, Jonasch, Eric, Gao, Jianjun, Adibi, Mehrad, Kamat, Ashish M., Navai, Neema, Pisters, Louis L., Dinney, Colin, Matin, Surena F., Shah, Amishi Y.
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.01.2022; John Wiley and Sons Inc; Wiley
• Subjects: Ablation; Bacillus Calmette–Guerin; Biopsy; Bladder cancer; Cancer therapies; Chemotherapy; endoscopic resection; Endoscopy; Hemodialysis; Histology; Hydronephrosis; Immunotherapy; Lasers; mitomycin; Oncology; Original; Patients; Software; Statistical analysis; Surgery; Surveillance; Tumors; upper tract urothelial carcinoma; Bacillus Calmette–Guerin; upper tract urothelial carcinoma; chemotherapy; endoscopic resection; mitomycin; immunotherapy

Objectives Multimodal kidney‐preserving (MKP) strategies may be an option for patients with localised or locally advanced high‐risk upper tract urothelial carcinoma (UTUC) who have a relative contraindication for nephroureterectomy (NU). Materials and methods We studied patients with UTUC who were m...